US stock · Healthcare sector · Medical Devices
Company Logo

Bruker Corporation

BRKRNASDAQ

60.75

USD
-1.33
(-2.14%)
Market Closed
33.75P/E
24Forward P/E
1.62P/E to S&P500
8.999BMarket CAP
0.29%Div Yield
Scale: |
View:
Currency: USD, in millions
1998
1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Income Statement
Revenue
42
65
77
93
116
261
284
298
436
548
1,107
1,115
1,305
1,652
1,791
1,839
1,809
1,624
1,611
1,766
1,896
2,073
1,988
2,418
COGS
- -
28
36
44
56
145
166
172
237
294
602
596
699
899
960
1,034
1,046
915
869
953
996
1,077
1,048
1,208
Gross Profit
- -
37
41
49
60
116
118
126
199
253
505
519
606
753
831
805
763
709
743
813
900
995
940
1,210
Gross Profit Ratio
- -
56.51%
53.54%
52.97%
51.99%
44.44%
41.66%
42.28%
45.74%
46.23%
45.61%
46.53%
46.44%
45.56%
46.41%
43.78%
42.20%
43.64%
46.08%
46.04%
47.48%
48.02%
47.29%
50.03%
Operating Expenses
42
33
40
46
55
126
120
115
163
199
388
382
450
584
649
635
646
557
546
583
631
696
678
782
R&D Expenses
- -
15
20
18
21
38
43
41
50
58
134
126
141
177
195
191
174
146
149
163
173
188
198
221
Selling, G&A Exp.
- -
15
20
28
34
78
76
74
113
140
255
255
303
407
454
444
451
403
391
416
453
505
478
561
General and Admin. Exp.
- -
15
20
28
34
78
76
74
113
140
255
70
303
407
454
444
451
403
391
416
453
505
478
- -
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
186
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
42
3
- -
(0)
0
10
- -
- -
- -
- -
- -
- -
6
- -
- -
- -
21
9
6
4
5
4
3
- -
COGS and Expenses
42
62
76
89
111
270
286
287
399
493
990
978
1,149
1,483
1,609
1,669
1,692
1,473
1,415
1,536
1,627
1,774
1,726
1,990
Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
1
1
1
0
1
1
1
3
- -
Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
8
6
7
14
13
13
13
13
15
13
16
14
- -
Depreciation and Amortization
- -
3
4
6
8
17
10
9
13
13
30
30
36
3
59
61
60
53
54
64
65
76
80
89
EBITDA
(0)
6
7
12
4
9
5
21
48
61
123
167
190
154
211
198
171
191
244
275
321
371
317
479
EBITDA ratio
(0.38)%
8.85%
8.68%
13.00%
3.49%
3.47%
1.70%
6.89%
10.94%
11.13%
11.09%
14.94%
14.59%
9.33%
11.78%
10.74%
9.48%
11.76%
15.16%
15.60%
16.93%
17.91%
15.95%
19.82%
Operating Income
(0)
3
1
3
6
(10)
(1)
11
31
50
108
137
156
156
156
148
105
146
177
215
262
301
248
413
Operating Income ratio
(0.38)%
4.91%
0.96%
3.53%
4.94%
(3.71)%
(0.39)%
3.57%
7.04%
9.13%
9.77%
12.27%
11.93%
9.42%
8.71%
8.06%
5.83%
8.97%
11.00%
12.16%
13.84%
14.52%
12.49%
17.09%
Total Other Income Exp.(Gains)
- -
(1)
2
3
(10)
2
(4)
1
4
(1)
(15)
(8)
(6)
(10)
(18)
(24)
(4)
(18)
0
(17)
(18)
(21)
(23)
(20)
Income Before Tax
- -
2
2
6
(4)
(8)
(5)
12
34
49
93
129
150
146
138
125
101
128
178
198
245
280
226
394
Income Before Tax ratio
- -
2.88%
3.03%
6.48%
(3.56)%
(3.00)%
(1.72)%
4.02%
7.90%
8.88%
8.42%
11.58%
11.50%
8.81%
7.72%
6.77%
5.60%
7.88%
11.02%
11.20%
12.91%
13.53%
11.36%
16.28%
Income Tax Expense (Gain)
- -
1
0
2
2
10
3
8
16
17
28
48
53
52
60
43
42
23
23
118
64
82
64
113
Net Income
- -
1
2
4
(6)
(18)
(8)
4
18
32
65
81
95
92
78
80
57
102
154
79
180
197
158
277
Net Income Ratio
- -
1.93%
2.94%
3.92%
(5.33)%
(6.73)%
(2.75)%
1.23%
4.24%
5.76%
5.86%
7.29%
7.31%
5.59%
4.33%
4.35%
3.13%
6.26%
9.53%
4.45%
9.48%
9.51%
7.94%
11.46%
EPS
- -
0.03
0.04
0.07
(0.11)
(0.22)
(0.09)
0.04
0.18
0.30
0.40
0.50
0.58
0.56
0.47
0.48
0.34
0.60
0.95
0.50
1.15
1.27
1.03
1.81
EPS Diluted
- -
0.03
0.04
0.07
(0.11)
(0.22)
(0.09)
0.04
0.18
0.30
0.39
0.49
0.58
0.55
0.46
0.48
0.33
0.60
0.95
0.49
1.14
1.26
1.02
1.79
Weighted Avg. Shares Outs.
46
46
49
55
55
81
87
90
102
104
163
164
164
165
166
167
168
168
161
158
156
155
153
153
Weighted Avg. Shares Outs. Dil.
46
46
50
55
55
81
87
90
103
107
166
165
166
167
167
169
170
169
162
159
157
157
155
155
Balance Sheet
Cash and Cash Equivalents
- -
2
22
8
32
63
33
53
52
73
166
207
230
246
311
439
320
267
342
325
322
678
682
1,068
Short-Term Investments
- -
- -
73
62
15
14
45
46
- -
- -
2
- -
- -
- -
- -
- -
178
201
158
114
- -
7
50
100
Cash & Short-Term Investments
- -
2
95
70
47
77
78
100
52
73
168
207
230
246
311
439
498
468
500
439
322
685
732
1,168
Net Receivables
- -
12
12
16
27
55
67
59
89
122
172
184
233
283
289
308
293
235
244
319
357
362
335
417
Inventory
- -
25
37
48
68
110
108
96
135
171
425
423
511
576
612
590
477
422
440
486
510
577
692
710
Other Current Assets
- -
1
4
5
4
9
19
11
19
29
56
60
77
89
98
96
98
107
91
114
115
172
166
177
Total Current Assets
- -
42
147
139
145
251
271
266
295
396
821
874
1,051
1,194
1,310
1,432
1,366
1,232
1,276
1,359
1,304
1,796
1,925
2,472
PP&E
- -
25
26
37
53
81
85
72
90
103
221
223
234
249
284
300
250
231
239
267
271
372
463
406
Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
40
41
46
48
98
100
116
127
128
131
131
170
276
293
320
- -
Intangible Assets
- -
0
2
2
3
13
12
19
6
4
6
5
136
136
117
106
84
75
70
82
219
233
229
772
Goodwill and Intangible Assets
- -
0
2
2
3
13
12
19
45
45
52
52
234
237
233
233
212
205
200
252
494
526
550
772
Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
13
13
17
18
19
30
53
77
57
51
61
72
- -
Other Non-Current Assets
- -
- -
9
11
2
6
3
4
3
10
22
9
18
14
13
5
7
10
17
14
8
17
40
- -
Total Non-Current Assets
- -
26
37
50
58
100
100
95
138
158
296
299
499
516
547
556
499
499
533
590
824
975
1,124
1,178
Other Assets
64
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
64
67
185
189
203
351
372
361
433
553
1,116
1,172
1,550
1,711
1,856
1,988
1,865
1,731
1,808
1,949
2,129
2,772
3,049
3,650
Accounts Payable
- -
7
8
10
10
23
23
14
23
33
43
269
64
72
70
75
76
72
86
91
105
118
135
147
Short-Term Debt
- -
2
- -
4
15
19
12
8
22
32
41
22
214
84
1
1
1
1
20
- -
19
21
24
112
Tax Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
56
61
10
37
51
24
45
60
70
117
- -
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
24
45
- -
- -
352
350
347
279
255
225
199
221
241
307
198
Other Current Liabilities
- -
20
29
26
33
67
76
89
150
164
391
249
553
248
261
226
227
227
194
235
256
266
327
481
Total Current Liabilities
- -
29
36
39
58
109
111
112
195
253
520
540
832
756
682
649
583
555
525
525
599
646
792
939
Long-Term Debt
- -
13
12
11
8
26
28
21
23
6
183
116
87
219
336
354
354
266
392
416
323
813
842
1,222
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
34
29
33
35
34
37
44
47
49
38
43
51
- -
Deferred Tax Liabilities
- -
9
7
8
7
- -
- -
- -
- -
- -
- -
25
19
24
12
23
18
10
10
24
51
49
43
- -
Other Non-Current Liabilities
- -
6
5
3
3
14
15
20
23
35
101
38
56
54
82
79
101
124
142
202
212
304
347
405
Total Non-Current Liabilities
- -
28
24
22
19
40
43
41
46
41
284
213
191
330
465
490
510
443
591
691
624
1,209
1,283
1,627
Other Liabilities
54
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Lease Obligations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
68
68
- -
Total Liabilities
54
57
60
62
77
148
154
153
241
294
804
753
1,022
1,086
1,147
1,138
1,093
998
1,115
1,215
1,224
1,854
2,075
2,565
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
- -
0
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
2
2
2
- -
Retained Earnings
- -
6
9
12
6
(14)
(22)
(19)
17
48
173
254
349
442
519
599
656
757
885
942
1,103
1,275
1,407
1,708
Other Compreh. Income(Loss)
- -
(19)
(20)
(22)
2
16
25
10
24
38
138
154
152
143
138
182
28
(44)
(76)
27
17
(26)
4
(8)
Other Total Stockhold. Equity
10
22
135
137
118
199
214
215
149
172
(0)
8
22
36
48
63
80
11
(125)
(245)
(225)
(344)
(451)
- -
Total Stockholders Equity
10
10
124
128
126
202
217
208
191
259
312
417
525
622
707
846
766
726
686
725
897
907
961
1,085
Total Liab.&Stockhold. Equity
64
67
185
189
203
351
371
361
433
553
1,116
1,170
1,547
1,707
1,853
1,984
1,859
1,724
1,802
1,940
2,120
2,761
3,036
3,650
Minority Interest
- -
- -
- -
- -
- -
0
0
0
0
1
1
2
3
3
3
4
6
7
7
8
9
10
13
0
Total Liabilities & Equity
64
67
185
189
203
351
372
361
433
553
1,116
1,172
1,550
1,711
1,856
1,988
1,865
1,731
1,808
1,949
2,129
2,772
3,049
3,650
Cash Flow Statement
Net Income
- -
1
2
4
(6)
(18)
(8)
4
18
32
65
81
95
92
78
80
57
102
154
79
180
197
158
277
Depreciation and Amortization
- -
3
4
6
8
17
10
9
13
13
30
30
36
3
59
61
60
53
54
64
65
76
80
89
Deferred Income Tax
- -
- -
(3)
0
(2)
3
0
(2)
1
(2)
(2)
(3)
(4)
(5)
(12)
7
(9)
(29)
(23)
28
(15)
(5)
(23)
(6)
Stock Based Compensation
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
7
8
8
7
9
8
9
11
11
10
16
17
Change in Working Capital
- -
(0)
(4)
(21)
(22)
(11)
(7)
32
9
(18)
10
37
(6)
(102)
(58)
(46)
(39)
46
(89)
(41)
(42)
(75)
70
(126)
Accounts Receivable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(9)
(27)
(53)
2
(19)
(15)
45
(8)
(56)
(31)
(5)
41
(95)
Inventory
- -
(10)
(13)
(15)
(15)
(1)
8
5
(12)
(26)
8
22
(68)
(112)
(50)
6
5
(5)
(43)
(7)
(36)
(60)
(92)
(67)
Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
6
7
9
5
7
9
13
(20)
34
5
16
(2)
62
Other Working Capital
- -
12
111
100
87
142
160
154
22
20
36
10
55
22
(13)
(6)
(44)
(29)
9
(17)
15
(38)
80
20
Other Non-Cash Items
- -
1
1
(0)
10
3
3
0
(4)
4
4
(1)
28
91
59
36
37
49
25
13
41
11
31
30
Cash Provided by Operating Activities
- -
5
(0)
(11)
(11)
(6)
(1)
42
38
28
107
150
156
88
133
145
114
229
131
154
240
213
332
282
CAPEX
- -
(4)
(6)
(18)
(16)
(5)
(7)
(3)
(8)
(16)
(47)
(16)
(32)
(54)
(73)
(50)
(34)
(34)
(37)
(44)
(49)
(73)
(97)
(92)
Acquisitions Net
- -
(0)
0
- -
(1)
(5)
- -
(6)
(26)
(4)
(11)
(2)
(270)
(14)
(24)
(11)
21
(28)
(24)
(66)
(192)
(90)
(59)
(65)
Purchases of Investments
- -
- -
(92)
(3)
(1)
(15)
(5)
(1)
- -
- -
(0)
- -
- -
- -
- -
- -
(212)
(159)
(127)
(119)
- -
(6)
(151)
(149)
Sales/Maturities of Investments
- -
- -
- -
14
48
15
12
- -
46
- -
10
- -
- -
- -
- -
- -
19
119
165
187
117
- -
115
108
Other Investing Activities
- -
- -
12
(1)
- -
- -
(0)
(0)
(0)
(0)
1
- -
3
- -
3
1
3
1
1
12
0
11
0
5
Cash Used for Investing Activities
- -
(4)
(86)
(7)
30
(10)
(2)
(10)
12
(21)
(48)
(18)
(299)
(69)
(93)
(60)
(202)
(102)
(22)
(30)
(123)
(158)
(193)
(192)
Debt Repayment
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(86)
(22)
(29)
(300)
(2)
(1)
(130)
(0)
(151)
(223)
(382)
(306)
(3)
Common Stock Issued
- -
- -
110
0
0
- -
14
0
2
20
4
2
6
3
5
8
8
11
12
20
9
11
3
7
Common Stock Repurchased
- -
- -
- -
- -
(2)
(0)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(90)
(160)
(152)
- -
(142)
(123)
(153)
Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
(23)
- -
(0)
- -
- -
- -
- -
- -
(26)
(25)
(25)
(25)
(25)
(24)
Other Financing Activities
- -
0
(5)
6
6
(8)
(8)
(8)
(66)
(10)
(215)
1
184
29
330
20
(0)
41
147
150
126
838
289
492
Cash Used/Provided by Financing Activities
- -
0
105
6
4
(8)
7
(7)
(64)
9
(235)
(84)
168
3
34
27
7
(168)
(27)
(159)
(112)
300
(162)
319
Effect of Forex Changes on Cash
- -
(0)
0
(1)
1
2
3
(4)
4
4
10
(7)
(2)
(7)
(10)
17
(38)
(11)
(7)
18
(7)
1
26
(23)
Net Change In Cash
- -
1
19
(13)
24
(22)
7
21
(10)
21
(166)
41
23
16
65
128
(119)
(52)
75
(17)
(3)
356
4
386
Cash at the End of Period
- -
2
22
8
32
63
33
53
52
73
166
207
230
246
311
439
320
267
342
329
326
682
686
1,072
Cash at the Beginning of Period
- -
1
2
22
8
85
25
33
63
52
332
166
207
230
246
311
439
320
267
346
329
326
682
686
Free Cash Flow
- -
1
(6)
(29)
(27)
(12)
(8)
39
30
12
60
134
124
33
60
95
81
195
94
111
191
140
235
190
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -